Literature DB >> 10708107

Chylomicron metabolism in patients submitted to cardiac transplantation.

C G Vinagre1, N A Stolf, E Bocchi, R C Maranhão.   

Abstract

BACKGROUND: Development of coronary graft disease is the most important cause of late heart graft failure. Alterations in plasma lipid profile are frequent in heart transplant (HT) patients, but they seem not to be prominent. Currently, the metabolism of chylomicrons, the lipoproteins that carry dietary lipids absorbed by the intestine, was evaluated because chylomicron remnants are considered atherogenic.
METHODS: An emulsion labeled with 3H-triolein and 14C-cholesteryl oleate and known to mimic the metabolic behavior of chylomicrons was injected intravenously after a 12-hr fast into 34 HT patients, 24 patients with end-stage heart failure (ESHF), and 30 healthy normolipidemic subjects. The plasma disappearance curves of the radioisotopes were determined from blood samples collected over 1 hr. In some of the patients and in controls, in vitro postheparin lipolytic activity was measured and an oral fat load test with postprandial measurement of triglyceridemia was performed.
RESULTS: Fractional clearance rate (in m(-1), median [25%; 75%]) of both emulsion 3H-triolein and 14C-cholesteryl oleate was extremely diminished in HT patients (HT: 0.0114 [0.0114; 0.0179] and 0.2x10(-8) [0.2x10(-8); 0.0041, respectively]; ESHF: 0.0226 [0.0223; 0.0568] and 0.0160 [0.0055; 0.0189]; control subjects: 0.0270 [0.0226; 0.0392] and 0.0090 [0.0042; 0.0180], respectively, P<0.05). HT patients also had reduced postheparin lipolysis and marked elevation of postprandial triglyceridemia compared with the controls.
CONCLUSIONS: HT patients develop accumulation in the plasma of chylomicrons and their remnants. The observed alterations were so intense that they may suggest an important involvement of atherogenic chylomicron remnants in coronary graft disease.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10708107     DOI: 10.1097/00007890-200002270-00012

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  4 in total

1.  Lipid nanoparticles for amphotericin delivery in the treatment of American tegumentary leishmaniasis.

Authors:  Regina Maia de Souza; Raul Cavalcante Maranhão; Elaine Rufo Tavares; Fabíola Branco Filippin-Monteiro; Antônio Carlos Nicodemo; Aleksandra Tiemi Morikawa; Edite Hatsumi Yamashiro Kanashiro; Valdir Sabbaga Amato
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

2.  Plasma kinetics of free and esterified cholesterol in familial hypercholesterolemia: effects of simvastatin.

Authors:  Raul D Santos; Ana P M Chacra; Aleksandra Morikawa; Carmen C Vinagre; Raul C Maranhão
Journal:  Lipids       Date:  2005-07       Impact factor: 1.880

3.  Metabolism of a lipid nanoemulsion resembling low-density lipoprotein in patients with grade iii obesity.

Authors:  Simone Alves Dantas; Elisabeth Salvatori Ficker; Carmen G C Vinagre; Barbara Maria Ianni; Raul Cavalcante Maranhão; Charles Mady
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

4.  Removal of Chylomicron Remnants from the Bloodstream is Delayed in Aged Subjects.

Authors:  Carmen G Vinagre; Fatima R Freitas; Carlos H de Mesquita; Juliana C Vinagre; Ana Carolina Mariani; Roberto Kalil-Filho; Raul C Maranhão
Journal:  Aging Dis       Date:  2018-08-01       Impact factor: 6.745

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.